FOXO1 and ovarian carcinoma: Furthermore, the Wnt/β-catenin signaling pathway has been shown to be involved in OC progression, and miR-27a activates Wnt/β-catenin signaling by targeting FOXO1, which promotes EMT in ovarian cancer [27].